Many investors are still learning about the various metrics that can be useful when analysing a stock. This article ...

Bristol Myers' Opdivo SC wins EU approval as the first PD-1 inhibitor for subcutaneous use across multiple solid tumor ...

Here are the latest stock rating upgrades by Seeking Alpha analysts: Nvidia (NASDAQ:NVDA). Sell to hold by Max Molter. Nvidia ...

Combined with the last dividend raise by +3.3% in December 2024, building upon the 10Y growth profile at +5.27%, we believe ...

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q1 CY2025 results , but sales fell by 5.6% year on year to $11.2 billion. The company’s full-year revenue guidance of $46.3 billion ...

BMY stock offers value with a sub-7x P/E, 6% dividend yield, and strong earnings. Discover why it’s a compelling buy despite ...

The U.S. drugmaker is turning to deals at a time when two of its top drugs, blood cancer treatment Revlimid and blood thinner Eliquis, face generic competition. Karuna’s crown jewel, an ...

The stock's fall snapped a four-day winning streak.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...